… inhibition of acid … syndrome coronavirus 2 (SARS-CoV-2) or vesicular stomatitis virus (VSV)
pseudoviral particles (pp-VSV) presenting SARS-CoV-2 spike protein (pp-VSV-SARS-CoV-2 …

… -VSV-SARS-CoV-2 spike required activation of acid sphingomyelinase … acid sphingomyelinase
activity in nasal epithelial cells and prevented pp-VSV-SARS-CoV-2 spike-induced acid …

… to evaluate the rationale for repurposing functional inhibitors of acid sphingomyelinase (FIASMAs),
several of which are approved medicines, for the treatment of SAR‐CoV‐2 infections. …

… acid synthase inhibitors as drug candidates for the prevention and treatment of COVID-19 by
inhibiting SARS-CoV-… suggest that FAS inhibitors can potently inhibit SARS-CoV-2 infection …

… host-pathogen interface, to fight SARS-CoV-2 infection. We find that fluoxetine, … inhibitor of
acid sphingomyelinase (FIASMA), efficiently inhibited the entry and propagation of SARS-CoV-…

… inhibitors that target the PI3 kinase VPS34 or fatty acid metabolism for anti-severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-… are potent SARS-CoV-2 inhibitors. Mechanistic …

… inhibitory effect against the SARS-CoV-2 furin enzyme and spiked glycoprotein through different
acid… potential therapeutic agents in the fight against the SARS-CoV-2 virus. On the other …

… acid was screened as a potential new drug. Moreover, molecular docking showed folic acid
could target on SARS-CoV… RNAi to verify whether folic acid antagonises SARS-CoV-2 N. Cell…

… In this study, we identified an additional ASM-independent inhibition of SARS-CoV-2
replication by a fluoxetine derivative compared to previous studies. Furthermore, we show that the …

… The newly identified SARS coronavirus (SARS-CoV) can be transmitted … acid (ATA) on
SARS-CoV replication in cell culture, and found that ATA could drastically inhibit SARS-CoV …